Stelvio Therapeutics Company

Stelvio Oncology is developing a personalized approach to glioblastoma treatment. Their team has core competencies of scientific creativity, clinical excellence and professional management required to successfully commercialize novel drug therapies and precision medicine diagnostics.
Technology:
Personalised Medicine
Industry:
Early Drug Development
Headquarters:
San Diego, California, United States
Founded Date:
2017-03-01
Employees Number:
11-50
Funding Status:
Seed
Investors Number:
2
Estimated Revenue:
Less than $1M
Last Funding Date:
2017-05-05
Last Funding Type:
Seed
Register and Claim Ownership